Invention Grant
- Patent Title: AXL kinase inhibitors and use of the same
-
Application No.: US16376452Application Date: 2019-04-05
-
Publication No.: US10888562B1Publication Date: 2021-01-12
- Inventor: Adam Siddiqui-Jain , Paul Flynn , Akihito Nonoyama , Akihito Kiguchiya
- Applicant: Sumitomo Dainippon Pharma Oncology, Inc
- Applicant Address: US MA Cambridge
- Assignee: Sumitomo Dainippon Pharma Oncology, Inc
- Current Assignee: Sumitomo Dainippon Pharma Oncology, Inc
- Current Assignee Address: US MA Cambridge
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D403/12 ; A61P35/02 ; A61K31/519
Abstract:
Tartrate salts of the compound of structure (I), crystalline forms thereof, and therapeutic applications thereof for treating solid tumors (e.g., advanced solid tumor) or hematopoietic cancers. Also provided herein are methods for synthesizing the tartrate salts and the crystalline forms thereof.
Public/Granted literature
- US11013741B1 AXL kinase inhibitors and use of the same Public/Granted day:2021-05-25
Information query
IPC分类:
